In a prospective phase I clinical trial assessing TARE efficacy and safety outcomes in heavily pretreated patients who experienced local tumor progression, additional HAIP chemotherapy after radioembolization resulted in 50% reduction in CEA levels [175]. Here, CEACAM5 is linked to neoplasm.